|
Announcement distributed December 10, 2012
A rule published by the U.S. Consumer Product Safety Commission (CPSC)
codifies the statement of policy on animal testing that provides guidance
for manufacturers of products subject to the Federal Hazardous Substances
Act (FHSA) regarding replacement, reduction, and refinement of animals.
Codification of this policy is intended to make CPSC's animal testing
policy and test methods recommended by ICCVAM and accepted by CPSC more
transparent and accessible to interested parties.
The rule was published December 10, 2012, in the Federal Register (77 FR 73286). The rule
includes comments received on the proposal and CPSC responses to the
comments. The rule also includes the relevant amendments made to the text
of 16 CFR part 1500. The statement of policy is effective January 9, 2013.
View Federal Register notice  -
View notice as webpage
In a related notice, the CPSC announced amendments to its regulations on
the CPSC's animal testing methods under the FHSA. The announcement, also
published in today's Federal Register (77 FR 73290) includes comments
received on the proposed rule and CPSC responses to the comments. The rule
also includes revisions to animal testing regulations and explanations of
the rationale for the revisions. The rule takes effect January 9, 2013.
View Federal Register notice -
View notice as webpage
The FHSA (15 U.S.C. 1261-1278) requires appropriate cautionary labeling to
alert consumers to the potential hazards that certain hazardous household
products may present. These include products that are toxic, corrosive,
irritants, flammable, combustible, or strong sensitizers. The changes to
the FHSA announced today clarify the criteria used for classification of
substances as "highly toxic," "toxic," "corrosive," "irritant," "primary
irritant," and "eye irritant." The changes emphasize that the use of in
vitro and other alternative test methods, including a weight-of-evidence
approach, and prior human experience are recommended over in vivo animal
tests wherever possible. Furthermore, the CPSC reiterates its preference
for reliable human experience over animal test data.
CPSC has also established a page on its website
 regarding ICCVAM
recommendations and new developments in test methods that avoid or further reduce or refine animal testing.
According to the ICCVAM Authorization Act, ICCVAM member agencies should
promote and encourage the development and use of alternatives to animal
test methods for regulatory purposes. Since the establishment of ICCVAM,
the CPSC has approved, where applicable, recommendations made by ICCVAM to
reduce and refine animal testing applicable to test methods under the
FHSA. A table summarizing U.S. and international regulatory acceptance of alternative test methods,
which includes methods recommended by ICCVAM applicable to testing under the FHSA, is available on
the ICCVAM website.
This announcement was originally distributed via the ICCVAM-all email list.
Subscribing to the ICCVAM-all email list will enable you to be notified directly of NICEATM and ICCVAM
activities. Subscribers receive email notification of publication of NICEATM and ICCVAM Federal Register
notices, availability of NICEATM and ICCVAM reports, notices of upcoming meetings, requests for public
comments or data, and other events of interest to our stakeholders.
View more information about the ICCVAM-all email list
|
